Animal Parasiticides Market value to hit $7 billion by 2025: Global Market Insights, Inc.
/
Date23 Sep 2019
Email Print Friendly Share Selbyville, Delaware, Sept. 20, 2019 (GLOBE NEWSWIRE) — China animal parasiticides market is projected to expand at 8% CAGR during the... Read More →
BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
/
Date23 Sep 2019
Email Print Friendly Share BEIJING, China and CAMBRIDGE, Mass., Sept. 22, 2019 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company... Read More →
Brompton Funds Declare Distributions
/
Date23 Sep 2019
Email Print Friendly Share TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) — (TSX: DGS, GDV, GDV.PR.A, LBS, LBS.PR.A, LCS, OSP.PR.A, SBC, SBC.PR.A,) – Brompton Funds announces... Read More →
RomReal: Complementary Statement to Half Year Report 2019
/
Date23 Sep 2019
Email Print Friendly Share Dear Investors, Please find attached a complementary statement to the half year 2019 report and financial statements. For further information please... Read More →
Equinor ASA: Share buy-back
/
Date23 Sep 2019
Email Print Friendly Share Equinor has on 20 September 2019 purchased 312,917 own shares at Oslo Stock Exchange at an average price of 181.0001 Norwegian... Read More →
SEGGER makes its entire Ecosystem of tools available for AndesCores
/
Date23 Sep 2019
Email Print Friendly Share Monheim, Germany , Sept. 18, 2019 (GLOBE NEWSWIRE) — Segger SEGGER, leading supplier of software libraries, development tools, debug probes and... Read More →
Aedifica NV/SA: 2018/2019 Annual Financial Report
/
Date23 Sep 2019
Email Print Friendly Share Please find below the 2018/2019 Annual Financial Report of Aedifica (a public regulated real estate company under Belgian law). Attachments 2018/2019... Read More →
Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
/
Date23 Sep 2019
Email Print Friendly Share CAMBRIDGE, Mass., Sept. 20, 2019 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the... Read More →